132 related articles for article (PubMed ID: 24385779)
21. MiR-92a inhibits fibroblast-like synoviocyte proliferation and migration in rheumatoid arthritis by targeting AKT2.
Yu FY; Xie CQ; Jiang CL; Sun JT; Feng HC; Li C; Huang XW
J Biosci; 2018 Dec; 43(5):911-919. PubMed ID: 30541951
[TBL] [Abstract][Full Text] [Related]
22. MicroRNA-92a serves as a risk factor in sepsis-induced ARDS and regulates apoptosis and cell migration in lipopolysaccharide-induced HPMEC and A549 cell injury.
Xu F; Yuan J; Tian S; Chen Y; Zhou F
Life Sci; 2020 Sep; 256():117957. PubMed ID: 32534035
[TBL] [Abstract][Full Text] [Related]
23. miR-92a/DUSP10/JNK signalling axis promotes human pancreatic cancer cells proliferation.
He G; Zhang L; Li Q; Yang L
Biomed Pharmacother; 2014 Feb; 68(1):25-30. PubMed ID: 24332650
[TBL] [Abstract][Full Text] [Related]
24. Cell proliferation is induced in renal cell carcinoma through miR-92a-3p upregulation by targeting FBXW7.
Zeng R; Huang J; Sun Y; Luo J
Oncol Lett; 2020 Apr; 19(4):3258-3268. PubMed ID: 32256821
[TBL] [Abstract][Full Text] [Related]
25. Overexpression of MiR-138 Inhibits Cell Growth and Induces Caspase-mediated Apoptosis in Acute Promyelocytic Leukemia Cell Line.
Manafi Shabestari R; Alikarami F; Bashash D; Paridar M; Safa M
Int J Mol Cell Med; 2018; 7(1):24-31. PubMed ID: 30234070
[TBL] [Abstract][Full Text] [Related]
26. Expression of miR-92a, miR-224 and miR-25 in non-small cell lung cancer and their correlation with clinical characteristics.
Yuan H; Su J; Hu S; Wei P
Am J Transl Res; 2021; 13(5):5561-5567. PubMed ID: 34150158
[TBL] [Abstract][Full Text] [Related]
27. Locked nucleic acid inhibits miR-92a-3p in human colorectal cancer, induces apoptosis and inhibits cell proliferation.
Ahmadi S; Sharifi M; Salehi R
Cancer Gene Ther; 2016 Jul; 23(7):199-205. PubMed ID: 27199220
[TBL] [Abstract][Full Text] [Related]
28. Regulation of miR-92a on vascular endothelial aging via mediating Nrf2-KEAP1-ARE signal pathway.
Liu H; Wu HY; Wang WY; Zhao ZL; Liu XY; Wang LY
Eur Rev Med Pharmacol Sci; 2017 Jun; 21(11):2734-2742. PubMed ID: 28678311
[TBL] [Abstract][Full Text] [Related]
29. MicroRNA-92a antagonism attenuates lipopolysaccharide (LPS)-induced pulmonary inflammation and injury in mice through suppressing the PTEN/AKT/NF-κB signaling pathway.
Fu L; Zhu P; Qi S; Li C; Zhao K
Biomed Pharmacother; 2018 Nov; 107():703-711. PubMed ID: 30138892
[TBL] [Abstract][Full Text] [Related]
30. Butyrate inhibits pro-proliferative miR-92a by diminishing c-Myc-induced miR-17-92a cluster transcription in human colon cancer cells.
Hu S; Liu L; Chang EB; Wang JY; Raufman JP
Mol Cancer; 2015 Oct; 14():180. PubMed ID: 26463716
[TBL] [Abstract][Full Text] [Related]
31. Inhibition of miR-92a increases endothelial proliferation and migration in vitro as well as reduces neointimal proliferation in vivo after vascular injury.
Iaconetti C; Polimeni A; Sorrentino S; Sabatino J; Pironti G; Esposito G; Curcio A; Indolfi C
Basic Res Cardiol; 2012 Sep; 107(5):296. PubMed ID: 22890560
[TBL] [Abstract][Full Text] [Related]
32. MicroRNA-92a functions as an oncogene in colorectal cancer by targeting PTEN.
Zhang G; Zhou H; Xiao H; Liu Z; Tian H; Zhou T
Dig Dis Sci; 2014 Jan; 59(1):98-107. PubMed ID: 24026406
[TBL] [Abstract][Full Text] [Related]
33. Inhibition of miR-92a Suppresses Oxidative Stress and Improves Endothelial Function by Upregulating Heme Oxygenase-1 in db/db Mice.
Gou L; Zhao L; Song W; Wang L; Liu J; Zhang H; Huang Y; Lau CW; Yao X; Tian XY; Wong WT; Luo JY; Huang Y
Antioxid Redox Signal; 2018 Feb; 28(5):358-370. PubMed ID: 28683566
[TBL] [Abstract][Full Text] [Related]
34. In vitro and in vivo activity of miR-92a-Locked Nucleic Acid (LNA)-Inhibitor against endometrial cancer.
Torres A; Kozak J; Korolczuk A; Wdowiak P; Domańska-Glonek E; Maciejewski R; Torres K
BMC Cancer; 2016 Oct; 16(1):822. PubMed ID: 27782822
[TBL] [Abstract][Full Text] [Related]
35. MiRNA-92a promotes cell proliferation and invasion through binding to KLF4 in glioma.
Liu PJ; Ye YX; Wang YX; Du JX; Pan YH; Fang XB
Eur Rev Med Pharmacol Sci; 2019 Aug; 23(15):6612-6620. PubMed ID: 31378903
[TBL] [Abstract][Full Text] [Related]
36. MicroRNA-92a -mediated endothelial to mesenchymal transition controls vein graft neointimal lesion formation.
Zhong CM; Li S; Wang XW; Chen D; Jiang ZL; Zhang C; He XJ; Huang C; Jiang YJ; Wu QC
Exp Cell Res; 2021 Jan; 398(1):112402. PubMed ID: 33253710
[TBL] [Abstract][Full Text] [Related]
37. MiR-92a inhibits proliferation and promotes apoptosis of OSCC cells through Wnt/β-catenin signaling pathway.
Zheng TL; Cen K
Eur Rev Med Pharmacol Sci; 2020 May; 24(9):4803-4809. PubMed ID: 32432743
[TBL] [Abstract][Full Text] [Related]
38. Role of Intracellular and Extracellular MicroRNA-92a in Colorectal Cancer.
Yamada N; Nakagawa Y; Tsujimura N; Kumazaki M; Noguchi S; Mori T; Hirata I; Maruo K; Akao Y
Transl Oncol; 2013 Aug; 6(4):482-92. PubMed ID: 23908691
[TBL] [Abstract][Full Text] [Related]
39. Inhibition of microRNA-92a protects against ischemia/reperfusion injury in a large-animal model.
Hinkel R; Penzkofer D; Zühlke S; Fischer A; Husada W; Xu QF; Baloch E; van Rooij E; Zeiher AM; Kupatt C; Dimmeler S
Circulation; 2013 Sep; 128(10):1066-75. PubMed ID: 23897866
[TBL] [Abstract][Full Text] [Related]
40. MiR-92a regulates oral squamous cell carcinoma (OSCC) cell growth by targeting FOXP1 expression.
Guo J; Wen N; Yang S; Guan X; Cang S
Biomed Pharmacother; 2018 Aug; 104():77-86. PubMed ID: 29772443
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
